findmyKOL
Clinical trialNCT00847639CompletedPhase 2Interventional

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

SponsorCenter for International Blood and Marrow Transplant ResearchEnrollment30Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope National Medical Center

    Duarte, California, United States

  • H. Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida, United States

  • University of Minnesota Medical Center

    Minneapolis, Minnesota, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • University of Pennsylvania Hospital Center

    Philadelphia, Pennsylvania, United States

  • the University of Texas, M.D. Anderson Cancer Center

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2009
Primary completion
31 Jan 2013
Completion
31 Mar 2014
Last update posted
4 Apr 2014
Registered enrollment
30
Registry id
NCT00847639

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.